Loading...
Loading...
Browse all stories on DeepNewz
VisitOxford/AstraZeneca Scientists Develop Bubonic Plague Vaccine for Black Death Amid UK Stockpile Concerns
Jan 4, 2025, 06:35 PM
Scientists from Oxford University and AstraZeneca are developing a vaccine for the bubonic plague, responding to concerns about a potential superbug strain of the Black Death. Military experts have advised the UK government to stockpile supplies of this new inoculation. The initiative follows the team's previous work on the Covid-19 vaccine, highlighting ongoing efforts to prepare for emerging infectious diseases.
View original story
Markets
No • 50%
Yes • 50%
Public health campaign announcement by UK Department of Health
Yes • 50%
No • 50%
Approval announcement from the UK Medicines and Healthcare products Regulatory Agency (MHRA)
No • 50%
Yes • 50%
Official announcement from the UK government or Ministry of Health
Less than 1 million • 25%
More than 10 million • 25%
5 to 10 million • 25%
1 to 5 million • 25%
Production reports from AstraZeneca or Oxford University
United States • 25%
Other • 25%
United Kingdom • 25%
European Union • 25%
Approval announcements from respective national regulatory agencies
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Official partnership announcements from Oxford/AstraZeneca or partnering companies